Cardium and Generx Featured on San Diego Biotechnology Connection(0) An article this morning on San Diego Biotechnology Connection website, discusses an important breakthrough in technology and regenerative medicine. The article provides details of Cardium Therapeutics (NYSE MKT: CXM) and its Generx product candidate, a DNA-based angiogenic growth factor therapeutic being developed for the potential treatment of patients with advanced coronary artery disease. The article titled, “Cardium Therapeutics reports advance – gene therapy process technology” was written by Rex Graham, a science journalist with a master’s degree in microbiology and a 30-year career Read More |
Contacts and informationHave an opinion or news that you want to share?
|
Social networks |
Most popular categories |